Laura Gehrcken

ORCID: 0000-0003-0216-9208
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Full-Duplex Wireless Communications
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • interferon and immune responses
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Antenna Design and Analysis
  • Polyomavirus and related diseases

University of Antwerp
2024-2025

Universitätsklinikum Erlangen
2021

Friedrich-Alexander-Universität Erlangen-Nürnberg
2021

Comprehensive Cancer Center Erlangen
2021

German Climate Computing Centre
2021

Abstract Background It remains challenging to obtain positive outcomes with chimeric antigen receptor (CAR)-engineered cell therapies in solid malignancies, like colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC). A major obstacle is the lack of targetable surface antigens that are not shared by healthy tissues. CD70 emerges as interesting target, due its stringent expression pattern tissue apparent role tumor progression a considerable amount malignancies. Moreover, also...

10.1186/s13045-024-01525-w article EN cc-by Journal of Hematology & Oncology 2024-02-09
Coming Soon ...